Overview

EMLA Cream in Hysteroscopy Practice

Status:
Unknown status
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to investigate the efficacy of 5% lidocaine 25 mg-prilocaine 25 mg/g cream (EMLA®) applied to the uterine cervix for reducing pain during diagnostic hysteroscopy, using a visual analogue scale (VAS) for pain, and whether it can replace general anesthesia that may be required for some cases of office hysteroscopy.
Phase:
Phase 2
Details
Lead Sponsor:
Ain Shams Maternity Hospital
Treatments:
EMLA